Beskrywing

According to a report by StrategyHelix, the global cannabis market is set to increase by US$ 70.5 miljard tydens 2022-2028, growing at a CAGR of 21.3% gedurende die voorspellingsperiode.

Die verslag verskaf up-to-date markgrootte data vir tydperk 2018-2021 en voorspel tot 2028 covering key market aspects like sales value for cannabis. The global cannabis market is segmented on the basis of product, compound type, aansoek, en streek. Op grond van produk, the global cannabis market has been segmented into capsules, concentrates, edibles, ander. Onder hierdie, the concentrates segment was accounted for the highest revenue generator in 2021. By compound type, the global cannabis market has been segmented into balanced THC and CBD, cannabidiol (CBD), tetrahydrocannabinol (THC). The THC segment is estimated to account for the largest share of the global cannabis market. Based on application, the global cannabis market is categorized into medical, recreational. The recreational segment held the largest share of the global cannabis market in 2021 and is anticipated to hold its share during the forecast period. Geografies, the global cannabis market is segmented into North America, Europa, Asia-Pacific, MEA (Midde-Ooste en Afrika), Latyns-Amerika. In 2021, North America made up the largest share of revenue generated by the cannabis market.

The global cannabis market is highly competitive. The cannabis market is dominated by key players, which are Aphira Inc., Aurora Cannabis Inc., Cannimed Therapeutics Inc., Canopy Growth Corporation, CV sciences Inc., Delta 9 Cannabis Inc., GW Pharmaceuticals plc, Tilray Brands Inc., VIVO Cannabis Inc. Competitive landscape gives a description of the competitive nature of the global cannabis market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

Die verslag is 'n waardevolle hulpbron vir maatskappye en organisasies wat in hierdie bedryf aktief is. It provides a cohesive picture of the cannabis market to help drive informed decision making for industry executives, beleidmakers, akademies, en ontleders.

Verslag Omvang

Produk: capsules, concentrates, edibles, ander
Compound type: balanced THC and CBD, cannabidiol (CBD), tetrahydrocannabinol (THC)
Toepassing: medical, recreational
Streek: Noord-Amerika, Europa, Asia-Pacific, MEA (Midde-Ooste en Afrika), Latyns-Amerika
Jare oorweeg: hierdie verslag dek die tydperk 2018 aan 2028
Company mentioned: Aphira Inc., Aurora Cannabis Inc., Cannimed Therapeutics Inc., Canopy Growth Corporation, CV sciences Inc., Delta 9 Cannabis Inc., GW Pharmaceuticals plc, Tilray Brands Inc., VIVO Cannabis Inc.

Sleutelvoordele vir belanghebbendes

– Get a comprehensive picture of the global cannabis market
– Bepaal groeisektore en -neigings vir belegging

INHOUDSOPGAWE

Deel 1. Inleiding
– Omvang van die studie
– Studietydperk
– Geografiese omvang
– Navorsingsmetodologie
Deel 2. Cannabis market overview
Deel 3. Market breakdown by product
– Capsules
– Concentrates
– Edibles
– Ander
Deel 4. Market breakdown by compound type
– Balanced THC and CBD
– Cannabidiol (CBD)
– Tetrahydrocannabinol (THC)
Deel 5. Markverdeling volgens toepassing
– Medical
– Recreational
Deel 6. Market breakdown by region
– Noord-Amerika
– Europa
– Asia-Pacific
– MEA (Midde-Ooste en Afrika)
– Latyns-Amerika
Deel 7. Sleutel maatskappye
– Aphira Inc.
– Aurora Cannabis Inc.
– Cannimed Therapeutics Inc.
– Canopy Growth Corporation
– CV sciences Inc.
– Delta 9 Cannabis Inc.
– GW Pharmaceuticals plc
– Tilray Brands, Inc.
– VIVO Cannabis Inc.
Oor StrategyHelix
Vrywaring